| 000 | 05062nam a2200433 i 4500 | ||
|---|---|---|---|
| 999 |
_c361059 _d361059 |
||
| 001 | 361059 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102121317.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 210718s2021 si a s |||| 0|eng d | ||
| 020 | _a9789811606915 | ||
| 024 | 7 |
_a10.1007/978-981-16-0691-5 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC112 _b2021 EB |
|
| 245 | 0 | 0 |
_aIntegrated Omics Approaches to Infectious Diseases _cedited by Saif Hameed, Zeeshan Fatima |
| 250 | _aFirst edition 2021 | ||
| 264 | 1 |
_aSingapore _bSpringer International Publishing _c2021 |
|
| 264 | 4 | _c2021 | |
| 300 |
_a1 recurso en línea (XIX, 542 páginas) _b78 ilustraciones, 69 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_aArchivo de texto _bPDF |
||
| 490 | 0 | _aBiomedical and Life Sciences (SpringerNature-11642) | |
| 490 | 0 | _aBiomedical and Life Sciences (R0) (SpringerNature-43708) | |
| 505 | 0 | _aChapter 1. Geno-Informatics for Prediction of Virulence and Drug Resistance in Bacterial Pathogens -- Chapter 2. Next Generation Sequencing: Challenges and Opportunities in Tuberculosis Research -- Chapter 3. Deciphering the role of epigenetic reprogramming in host-pathogen interactions -- Chapter 4. Genomic evidence provides the understanding of SARS-CoV-2 composition, divergence and diagnosis -- Chapter 5. Importance of Next Generation Sequencing in Viral Diagnostics -- Chapter 6. Bioinformatics application in CoVID19 -- Chapter 7. Emerging Transcriptomics approaches to decipher Mycobacterial complexities -- Chapter 8. Microarrays: A road map to uncover host pathogen interactions -- Chapter 9. Transcriptional Approach in the Identification of Drug Targets in Candida spp -- Chapter 10. Non-Coding RNA profiling: Potential Application in Infectious Diseases -- Chapter 11. RNA-seq analysis strategies to understand viral pathogenesis -- Chapter 12. Various Transcriptomic approaches & their applications to study small non-coding RNAs in Dengue and other viruses -- Chapter 13. Transcriptomic Approaches in Understanding Sars-COV-2 Infection -- Chapter 14. miRNA target prediction: Overview and applications -- Chapter 15. A Glimpse into Peptidomic Approach -- Chapter 16. Molecular mechanism of action of antimicrobial agents against clinically important human pathogens: A proteomic approach -- Chapter 17. Exploration of the mycobacterial proteome in the pathogenesis of TB: A perspective -- Chapter 18. Pathogenesis of Staphylococcus aureus and proteomic strategies for the identification of drug targets -- Chapter 19. Proteomics in the study of Host-Pathogen interactions -- Chapter 20. Significance of post-translational modifications in Apicomplexan parasites -- Chapter 21. An introduction to computational pipelines for analyzing untargeted metabolomics data for Leishmaniasis -- Chapter 22. Metabolomics: PromisingTool to Study Disease Biomarkers and Host-Pathogen Interactions -- Chapter 23. Lipidomics to study the role of lipid droplets in host-pathogen interactions -- Chapter 24. Lipid structure, function and lipidomic applications -- Chapter 25. Nanoparticles as Therapeutic Nanocargos affecting Epigenome of Microbial Biofilms -- Chapter 26. Malaria in the era of OMICS: Challenges and Way forward -- Chapter 27. Omics Approaches for Infectious Diseases -- Chapter 28. Pathogen-Omics: challenges and prospects in research and clinical settings. | |
| 520 | 3 | _aThis book examines applications of multi-omics approaches for understanding disease etiology, pathogenesis, host-pathogen interactions. It also analyzes the genetics, immunological and metabolic mechanisms underlying the infections. The book also explores genomics, transcriptomics, translational-omics, and metabolomics approaches to understand the pathogenesis and identify potential drug targets. It reviews the role of epigenetic reprogramming in shaping the host-pathogen interactions and presents bioinformatics application in the identification of drug targets. Further, it examines the potential applications of RNA sequencing and non-coding RNA profiling to identify the pathogenesis. Lastly, it offers the current challenges, technological advances, and prospects of using multi-omics technologies in infectious biology. | |
| 988 | _aSpringer_BiomedLife_2021 | ||
| 650 | 7 |
_2embne _9138404 _aEnfermedades infecciosas |
|
| 700 | 1 |
_aHameed, Saif. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aFatima, Zeeshan. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9789811606908 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811606922 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811606939 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-16-0691-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b02/2022 _dz _ek _zSI |
||